I wanted to see how other institutions, including health systems, structure the medication pump libraries. We currently have 4 different vendors for our large volume, syringe, epidural, and PCA pumps. Each pump has it's own subcommittee and chair that report to a larger multidisciplinary pump committee. Currently, the medication safety officer is the chair of the pump committee and in charge of all library maintenance, including upgrades.
I would love to hear how other institutions handle the pump libraries.
Thanks -
Maria Cumpston, PharmD, CPPS

As a matter of curiosity I'm interested in how other institutions are handling the Designated Person requirement in USP 800

1) Is your DP only responsible for USP 800 implementation or do they have other responsibilities?
2) How many FTEs do you have assigned to the DP role?
3) Does your DP draft the non-pharmacy related procedures?

Thanks!

Hi there!

Just curious if anyone has any unique systems developed for management of REMS medications throughout their healthcare system?

Does your organization have a pharmacist check all non-patient specific ADC replenishments (pyxis, omnicell...etc)?

If not, do you use a tech validation or tech-check-tech program? and\or do you rely on barcode technology on dispense and fill?

We have always had a pharmacist check pyxis replenishment stock and have not (re)-evaluated in a number of years since incorporating barcode validation on dispense, and on pyxis fill.

appreciate others perspective and any value added accounts of having a pharmacist check pyxis stock.

Nick Haar

Hello,

I’m interested in seeing if any of my colleagues at other facilities have been experiencing an increase in adverse events associated with the use of IV contrast in neurointerventional endovascular procedures.

To summarize briefly, we have recently observed an increase in events where these patients have experienced symptoms of stroke, seizure and encephalopathy post neurointerventional procedures with subsequent recovery. One common feature among these patients is the unexpected presence of IV contrast in the brain post procedure.

How many out there have Metoprolol IV on their ADM override lists?

Thank you,
Jeff Ferber, PharmD

We have seen an increase in the utilization of TXA in our OB population and questions regarding compatibility of these two drugs in the same line as infusions. Trissels has no compatibility data and I have not located in any other data to support administering these drugs together in the same line.

As we continue to stress our system through high census, acuity, etc, we are looking at signals or thresholds that would serve as proxies for the overall safety of our organization. Like many of you, we track a variety of metrics and respond as necessary, but does anyone have a system in place to signal you when there is a drift towards unsafe territory? Any ideas are appreciated.

We have a situation that has recurred several times, and we struggle with it every time.
Currently, there are no insulin pumps that have settings based on U-500 insulin. Periodically, we have patients who come in with U-500 in their pump, so their pump settings do not accurately reflect the number of units they are receiving. How do we document this pump in the EMR? We try to move away from their pump to our medications, but that comes with conversion issues as well.

Hi. I've in New Zealand and have just joined the MSOS group.